DMARD III adverse effects are typically which of the following?

DMARD III adverse effects are typically which of the following?

• A. Severe blood dyscrasia, hepatitis
• B. Hypertension
• C. Hair loss only
• D. Rash mild

Answer: (A)

The main idea is that the most significant, monitoring-worthy toxicities of DMARDs involve bone marrow suppression and liver injury. These drugs can affect rapidly dividing cells in the bone marrow, leading to blood dyscrasias such as anemia, leukopenia, and thrombocytopenia, which raise infection risk and bleeding concerns. They also can impair liver function, causing hepatitis, with elevated liver enzymes and possible jaundice. Because these effects are serious and often dose-related, they’re the adverse effects clinicians are most vigilant about and routinely monitor with blood counts and liver tests. Other potential adverse effects like hypertension, hair loss, or a mild rash are less characteristic of the major toxicity profile these medications typically pose, and they don’t drive the same level of laboratory monitoring or risk to patient safety.

The main idea is that the most significant, monitoring-worthy toxicities of DMARDs involve bone marrow suppression and liver injury. These drugs can affect rapidly dividing cells in the bone marrow, leading to blood dyscrasias such as anemia, leukopenia, and thrombocytopenia, which raise infection risk and bleeding concerns. They also can impair liver function, causing hepatitis, with elevated liver enzymes and possible jaundice. Because these effects are serious and often dose-related, they’re the adverse effects clinicians are most vigilant about and routinely monitor with blood counts and liver tests.

Other potential adverse effects like hypertension, hair loss, or a mild rash are less characteristic of the major toxicity profile these medications typically pose, and they don’t drive the same level of laboratory monitoring or risk to patient safety.